Wspólnotowy Serwis Informacyjny Badan i Rozwoju - CORDIS


SPAVACC Streszczenie raportu

Project ID: QLK2-CT-1999-00983
Źródło dofinansowania: FP5-LIFE QUALITY
Kraj: United Kingdom

New and improved recombinant JSRV proteins

A number of different new plasmid constructs were made for the expression of recombinant JSRV proteins. Expression and purification of the proteins was optimised and the proteins were used as immunogens or as antigens for immunological assays. The proteins have further use for similar studies. In the right dose, adjuvant and immunisation route one or more of the proteins may be a component of a future vaccine against OPA. The same proteins could also be employed in assays to monitor vaccine efficacy in inducing immune responses.


Christina COUSENS, (Senior Scientist)
Tel.: +44-131-4455111
Faks: +44-131-4456111
Adres e-mail
Śledź nas na: RSS Facebook Twitter YouTube Zarządzany przez Urząd Publikacji UE W górę